Bausch Health
BHC
#4707
Rank
โ‚น198.10 B
Marketcap
โ‚น530.46
Share price
1.62%
Change (1 day)
14.83%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2025 (TTM): โ‚น84.70

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is โ‚น91.39. In 2024 the company made an earnings per share (EPS) of -โ‚น11.31 an increase over its 2023 EPS that were of -โ‚น152.64.

EPS history for Bausch Health from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น84.70-849.14%
2024-โ‚น11.31-92.59%
2023-โ‚น152.64160.89%
2022-โ‚น58.51-76.64%
2021-โ‚น250.4368.45%
2020-โ‚น148.67-68.91%
2019-โ‚น478.16-57.11%
2018-โ‚น1,115-272.22%
2017โ‚น647.40-199.29%
2016-โ‚น652.00798.7%
2015-โ‚น72.55-128.31%
2014โ‚น256.28-204.62%
2013-โ‚น244.97602.7%
2012-โ‚น34.86

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-โ‚น22.61-124.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น89.51-197.94%๐Ÿ‡บ๐Ÿ‡ธ USA